[HTML][HTML] Oral delivery of proteins and peptides: Challenges, status quo and future perspectives

Q Zhu, Z Chen, PK Paul, Y Lu, W Wu, J Qi - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Proteins and peptides (PPs) have gradually become more attractive therapeutic molecules
than small molecular drugs due to their high selectivity and efficacy, but fewer side effects …

Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery

J Nicolas, S Mura, D Brambilla, N Mackiewicz… - Chemical Society …, 2013 - pubs.rsc.org
Design and functionalization strategies for multifunctional nanocarriers (eg, nanoparticles,
micelles, polymersomes) based on biodegradable/biocompatible polymers intended to be …

A holistic approach to targeting disease with polymeric nanoparticles

CJ Cheng, GT Tietjen, JK Saucier-Sawyer… - Nature reviews Drug …, 2015 - nature.com
The primary goal of nanomedicine is to improve clinical outcomes. To this end, targeted
nanoparticles are engineered to reduce non-productive distribution while improving …

Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery

Y Yun, YW Cho, K Park - Advanced drug delivery reviews, 2013 - Elsevier
As the field of biotechnology has advanced, oral protein delivery has also made significant
progress. Oral delivery is the most common method of drug administration with high levels of …

Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems

Y Xu, N Shrestha, V Préat, A Beloqui - Journal of controlled release, 2020 - Elsevier
Oral drug administration is one of the most preferred and simplest routes among both
patients and formulation scientists. Nevertheless, orally delivery of some of the most widely …

Mucus models to evaluate the diffusion of drugs and particles

JY Lock, TL Carlson, RL Carrier - Advanced drug delivery reviews, 2018 - Elsevier
Mucus is a complex hydrogel that acts as a natural barrier to drug delivery at different
mucosal surfaces including the respiratory, gastrointestinal, and vaginal tracts. To elucidate …

Fate of polymeric nanocarriers for oral drug delivery

L Plapied, N Duhem, A des Rieux, V Préat - Current opinion in colloid & …, 2011 - Elsevier
This review will focus on two polymeric nanocarriers: nanoparticles and micelles that have
been studied for oral drug delivery at preclinical level. Their potential for oral drug delivery …

Combinatorial peptide libraries: mining for cell-binding peptides

BP Gray, KC Brown - Chemical reviews, 2014 - ACS Publications
The surface of a cell represents a collection of macromolecules, which provides the cell with
a unique cellular landscape specific to the type and state of the cell. Ligands that …

Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs

F Antunes, F Andrade, F Araújo, D Ferreira… - European Journal of …, 2013 - Elsevier
In vitro cell culture models for studying oral drug absorption during early stages of drug
development have become a useful tool in drug discovery and development, with respect to …

Engineering nano‐and microparticles as oral delivery vehicles to promote intestinal lymphatic drug transport

YB Miao, YJ Lin, KH Chen, PK Luo… - Advanced …, 2021 - Wiley Online Library
Targeted oral delivery of a drug via the intestinal lymphatic system (ILS) has the advantages
of protecting against hepatic first‐pass metabolism of the drug and improving its …